The Need for Effective Safe Arthritis Pain Relief
Arthritis affects the lives of millions of people worldwide. Arthritis is inflammation of a joint or joints characterized by pain and stiffness. Osteoarthritis, the most common cause, is degenerative or mechanical arthritis where the surface of the bones and cartilage in the joints becomes damaged. In the UK at least 8 million people have osteoarthritis. Rheumatoid arthritis is where the body’s own immune system attacks the joints and it affects about 400,000 people in the UK.
New Development in Pain Relief - Fewer Drugs, Less Pain and More Living
ActiPatch® is a new and clinically proven drug free technology in the fight against arthritis pain. ActiPatch® is drug and ingredient-free so is safe for continuous use and can be used while taking any other medication. Unlike other arthritis medications, the ActiPatch® is drug and ingredient free and has no dangerous side-effects. In fact, ActiPatch® is completely sensation free, so the only thing you are going to feel is better.
An ongoing consumer survey of 2,000 UK ActiPatch users, of whom 890 reported osteoarthritis and rheumatoid as their cause of their pain, emphasises ActiPatch’s benefit for arthritis pain relief. In this survey, the users reported an initial pain score before using ActiPatch of 8.5 where 10 indicates the worst pain and 0 indicates no pain. This high level of average pain clearly indicates that current therapies for the management of arthritis pain are inadequate. After just a 1-week ActiPatch trial, 78% of the arthritis sufferers reported an average pain reduction of 4.5 points or 53% in their pain levels; most reported an improvement in the first three days.
ActiPatch is drug free, so unlike medications, there are no adverse effects and it is safe in the elderly, diabetics and those with heart, lung and kidney disease. ActiPatch can be used safely 24 hours per day.
About the author Ian Rawe is the Director of Clinical Research at BioElectronics Corporation, the manufacturer of ActiPatch® Therapy.